Global Biologics Market Trends And Strategies Of Major Players In The Biologics Market 2021-2030

4 Feb, 2021

The biologics market consists of sales of biologics and related services by entities (organizations, sole traders and partnerships) that produce biologics to treat and prevent various microbial diseases and cancers. Biological products include a wide range of products such as vaccines, allergenics, somatic cells, tissues, and recombinant therapeutic proteins. This industry includes establishments that produce products that are composed of sugars, proteins, nucleic acids, and combination of all these substances isolated from humans, animal and microorganisms or produced from biotechnology methods. Specifically, most biologic medicines are developed using recombinant DNA (rDNA) technology.

Global Biologics Market Size And Drivers:

The global biologics market is expected to grow from $253.41 billion in 2020 to $268.51 billion in 2021 at a compound annual growth rate (CAGR) of 6%. The growth is mainly due to the companies rearranging their operations and recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The market is expected to reach $420.55 billion in 2025 at a CAGR of 12%. Technology is expected to be a continued driver of market growth during this period. An area of particular development is likely to be physiology simulation modeling.

Request For A Sample For The Global Biologics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3606&type=smp

Trends In The Global Biologics Market

The early generation of biologics is losing its patent protection and are expected to face greater competition going forward from the entry of biosimilars into the market. Biosimilars are the pharmaceuticals that are developed to have similar properties to a biologic drug that has already been approved. Demand for biosimilars is being fueled by governments around the world trying to reduce healthcare costs.

Global Biologics Market Segments:

The global biologics market is further segmented based on type, distribution channel, route of administration, drug classification, mode of purchase and geography.
By Type: Monoclonal Antibodies (MAbs), Therapeutic Proteins, Vaccines.
By Distribution Channel: Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Others.
By Route Of Administration: Oral, Parenteral, Others.
By Drug Classification: Branded Drugs, Generic Drugs.
By Mode Of Purchase: Prescription-Based Drugs, Over-The-Counter Drugs.
Subsegments Covered: Anti-Cancer MAbs, Immunological MAbs, Anti-Infective Monoclonal Antibodies (MAbs), Neuropharmacological MAbs, Cardiovascular And Cerebrovascular MAbs, Other Monoclonal Antibodies (MAbs), Metabolic Disorders Therapeutic Proteins, Cancer Therapeutic Proteins, Cardiovascular Therapeutic Proteins, Immunological Therapeutic Proteins, Other Therapeutic Proteins, Anti-Infective Vaccines, Autoimmunity Vaccines, Other Vaccines
By Geography: The global biologics market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America is the largest region in the global biologics market, accounting for 53% of the total market.

Read More On The Report For The Global Biologics Market At:
https://www.thebusinessresearchcompany.com/report/biologics-global-market-report

Biologics Global Market Report 2021 is one of a series of new reports from The Business Research Company that provides biologics market overviews, analyzes and forecasts market size and growth for the global biologics market, biologics market share, biologics market players, biologics market segments and geographies, biologics market’s leading competitors’ revenues, profiles and market shares. The biologics market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)